TPE in Rennes Hospital
NCT03888417 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 190
Last updated 2023-04-12
Summary
To assess the indications, tolerance and side effects of therapeutic plasma exchange (TPE) performed at a University Hospital over 8 years
Conditions
- Therapeutic Plasma Exchange
Interventions
- DEVICE
-
Therapeutic plasma exchange (TPE)
All TPEs were performed by the centrifugation technique using the Fresenius Kabi COMTEC machine
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Christophe CAMUS, MD · Rennes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-15
- Primary Completion
- 2018-08-30
- Completion
- 2018-09-30
Countries
- France
Study Locations
More Related Trials
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire
NCT00331357 ·Status: UNKNOWN
-
An Investigation of rhTPO With Different Frequencies in the Management of ITP
NCT02139501 ·Status: COMPLETED ·Phase: PHASE3
-
American Trial Using Tranexamic Acid in Thrombocytopenia
NCT02578901 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
NCT00937131 ·Status: COMPLETED ·Phase: PHASE2
-
Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .
NCT05850481 ·Status: UNKNOWN
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia
NCT02334813 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Combined Platelet Transfusion
NCT06613425 ·Status: RECRUITING ·Phase: PHASE4
-
Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
NCT00907751 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts
NCT05583838 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
NCT05714969 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
NCT00128713 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy
NCT02391272 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Centrifugation Based and Membrane Based Plasma Exchange
NCT06652516 ·Status: COMPLETED ·Phase: NA
-
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
NCT05998759 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura
NCT06291025 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)
NCT03771378 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion
NCT01955811 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)
NCT04021173 ·Status: UNKNOWN ·Phase: PHASE2
-
A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
NCT02137681 ·Status: WITHDRAWN ·Phase: PHASE3
-
Immunomodulation With Eltrombopag in ITP
NCT04812483 ·Status: COMPLETED ·Phase: PHASE2
-
The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT01101295 ·Status: UNKNOWN
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
NCT03951623 ·Status: COMPLETED ·Phase: PHASE1